amgen shares jumped tuesday after an analyst raised his rating on the stock saying the biotechnology company is a strong play in the currently volatile market morgan stanley analyst matthew harrison upgraded shares of amgen ticker amgn to overweight from equal weight on tuesday he increased his 12month target for the stock price to 279 from 257